User profiles for Myron S. Cohen
 | Myron S CohenThe University of North Carolina @Chapel Hill Verified email at med.unc.edu Cited by 129365 |
[HTML][HTML] Prevention of HIV-1 infection with early antiretroviral therapy
Background Antiretroviral therapy that reduces viral replication could limit the transmission
of human immunodeficiency virus type 1 (HIV-1) in serodiscordant couples. Methods In nine …
of human immunodeficiency virus type 1 (HIV-1) in serodiscordant couples. Methods In nine …
Sexual transmission of HIV
Transmission through sexual contact accounts for 75 to 85 percent of the nearly 28 million
infections with the human immunodeficiency virus (HIV) that have occurred so far. The …
infections with the human immunodeficiency virus (HIV) that have occurred so far. The …
HIV treatment as prevention: debate and commentary—will early infection compromise treatment-as-prevention strategies?
Universal HIV testing and immediate antiretroviral therapy for infected individuals has been
proposed as a way of reducing the transmission of HIV and thereby bringing the HIV …
proposed as a way of reducing the transmission of HIV and thereby bringing the HIV …
Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection
The precise identification of the HIV-1 envelope glycoprotein (Env) responsible for
productive clinical infection could be instrumental in elucidating the molecular basis of HIV-1 …
productive clinical infection could be instrumental in elucidating the molecular basis of HIV-1 …
[HTML][HTML] Antiretroviral therapy for the prevention of HIV-1 transmission
Background An interim analysis of data from the HIV Prevention Trials Network (HPTN) 052
trial showed that antiretroviral therapy (ART) prevented more than 96% of genetically linked …
trial showed that antiretroviral therapy (ART) prevented more than 96% of genetically linked …
[HTML][HTML] Cabotegravir for HIV prevention in cisgender men and transgender women
…, A Rinehart, A Adeyeye, MS Cohen… - … England Journal of …, 2021 - Mass Medical Soc
Background Safe and effective long-acting injectable agents for preexposure prophylaxis (PrEP)
for human immunodeficiency virus (HIV) infection are needed to increase the options …
for human immunodeficiency virus (HIV) infection are needed to increase the options …
Subcutaneous REGEN-COV antibody combination to prevent Covid-19
…, RV Barnabas, DH Barouch, MS Cohen… - … England Journal of …, 2021 - Mass Medical Soc
Background REGEN-COV (previously known as REGN-COV2), a combination of the monoclonal
antibodies casirivimab and imdevimab, has been shown to markedly reduce the risk of …
antibodies casirivimab and imdevimab, has been shown to markedly reduce the risk of …
SARS-CoV-2 variants in patients with immunosuppression
… Myron S. Cohen, MD, … Representative sequences from the case reports are listed
according to the first author’s name ( 1,2,4,8,10 ). Mutations in the NTD supersite are …
according to the first author’s name ( 1,2,4,8,10 ). Mutations in the NTD supersite are …
Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1
Background Transmission of HIV-1 is predominantly by heterosexual contact in sub-Saharan
Africa, where sexually transmitted diseases (STDs) are also common. Epidemiological …
Africa, where sexually transmitted diseases (STDs) are also common. Epidemiological …
The role of sexually transmitted diseases in HIV transmission
SR Galvin, MS Cohen - Nature Reviews Microbiology, 2004 - nature.com
More than 42 million people worldwide are now infected with HIV, in spite of sustained
prevention activities. Although the spread of HIV has been primarily sexual, epidemiological …
prevention activities. Although the spread of HIV has been primarily sexual, epidemiological …
